Gathering life energy

Caring for human health

OEC    Mail   |

All
  • All
  • Products
  • News
  • Introduce the content
  • Enterprise gallery
Search

Securities code：603520

One space, one dream | Zhejiang Starry Pharmaceutical Co., Ltd. held the 24th anniversary celebration meeting of the company

One space, one dream | Zhejiang Starry Pharmaceutical Co., Ltd. held the 24th anniversary celebration meeting of the company

Autumn is high and crisp, ginkgo dance fan; Osmanthus fragrans are fragrant and fruitful. On September 15, the 24th anniversary celebration meeting of Zhejiang Starry Pharmaceutical Co., Ltd. was grandly held in Zhejiang company. The middle-level and above cadres of Zhejiang company attended the conference, and the middle-level and above cadres of local companies attended the teleconference. The meeting was presided over by Hu Jian, vice chairman and general manager of the company.

Annual output of 1,550 tons of non-ionic CT contrast agent series raw material project of Zhejiang Starry Pharmaceutical Co.

Annual output of 1,550 tons of non-ionic CT contrast agent series raw material project of Zhejiang Starry Pharmaceutical Co.Ltd

2022-04-06

Environmental Impact Assessment Information Announcement of Zhejiang Taizhou Hisyn Pharmaceutical Co.

Ltd. is located in Zhejiang Toumen Port Economic Development Zone, Nanyang Area (Medical and Chemical Park), the project intends to invest 23,870,000 yuan, in the A6 workshop to build an annual output of 100 tons of JSQ production line, which can achieve a sales income of 10,000,000 yuan, profits and taxes of 24 million yuan, foreign exchange earnings of 14 million U.S. dollars.

2022-03-14

The environmental impact assessment report and public participation statement of the project of Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd. with an annual output of 400 tons of iohexol and 200 tons of iodophor are publicized

The environmental impact assessment report and public participation statement of the project of Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd. with an annual output of 400 tons of iohexol and 200 tons of iodophor are publicized

2021-12-06

Hisyn environmental protection rectification plan - submitted (Environmental Protection Bureau filing version)

Hisyn environmental protection rectification plan - submitted (Environmental Protection Bureau filing version)See attachment for details

2020-01-08

Underground soil and groundwater survey and inspection report information disclosed in Zhejiang A plant

The testing of underground soil and groundwater in company A's factory area is now publicly available. See the attachment for details!

2019-10-25

Public announcement of environmental emergency plan of Jiangxi Starry Pharmaceutical Co., Ltd.

Public announcement of environmental emergency plan of Jiangxi Starry Pharmaceutical Co., Ltd.

2018-12-03

< 12 >
Facebook Linkedin Twitter Tumblr Pinterest

Copyright © Zhejiang Starry Pharmaceutical Co., Ltd.  All Rights Reserved.
Powered by www.300.cn

Business license

图片名称

WeChat

图片名称

Wap

CONTACT US

Tel: 0576-87718628 / 021-37916067

E-mail: sales@starrypharma.com

Zhejiang Starry Pharmaceutical Co., Ltd.

Add: No.l Starry Road of Xianju, Modern IndustriaL, Centralization Zone, Xianju, Zhejiang, China

Shanghai Starry Pharmaceutical Co., Ltd.

Add: No.500 Maoye Road,Jinshan District 201506, Shanghai city, China

Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd.

Add: Chemical and Medical Raw Materials Base, Linhai Park, Zhejiang, China

Jiangxi Starry Pharmaceutical Co., Ltd.

Add: North of the Wuyl Road,Salt chemical Base, Zhangshu, Jiangxi, 331200, P.R.China

Imax Diagnostic Imaging Limited

Add: Phoenix House, Room 137 Monahan Road, CorkT12H1XY Republic of lreland
E-mail:info@imaxdiagnostic.com
Tel: 00353 21 451 9990

REQUEST A QUOTE

SEND
图片名称